
Dr Javier Barallobre-Barreiro
BHF Intermediate Fellow
Contact details
Biography
Javier Barallobre-Barreiro is a Molecular Biologist by training and the main focus of his research is the biology of cardiac extracellular matrix. Javier joined King’s in 2011 as a Postdoctoral Researcher. He improved the available strategies to study the cardiovascular extracellular matrix and investigated the role of extracellular matrix protein fragmentation in cardiac disease. In 2016 he was awarded a Career Establishment Fellowship at King’s, and in 2019 he obtained a British Heart Foundation Intermediate Basic Science Research Fellowship, focused on the investigation of the roles of extracellular matrix remodelling in heart failure using preclinical models and clinical samples.
Research

Vascular Proteomics
Our group uses proteomics in combination with other -omics technologies, such as metabolomics, lipidomics and microRNA profiling, to integrate biological information in disease-specific networks that drive pathopysiological changes.
News
Beta-blockers reduce heart proteoglycan content potentially providing newly discovered health benefits
Researchers discover that beta-blockers can prevent build-up of proteoglycans, a group of proteins that accumulate in the heart of patients with heart failure.

Research

Vascular Proteomics
Our group uses proteomics in combination with other -omics technologies, such as metabolomics, lipidomics and microRNA profiling, to integrate biological information in disease-specific networks that drive pathopysiological changes.
News
Beta-blockers reduce heart proteoglycan content potentially providing newly discovered health benefits
Researchers discover that beta-blockers can prevent build-up of proteoglycans, a group of proteins that accumulate in the heart of patients with heart failure.
